Cite

    Wang, Y. et al. (2017). Baicalin inhibits human osteosarcoma cells invasion, metastasis, and anoikis resistance by suppressing the transforming growth factor-β1-induced epithelial-to-mesenchymal transition. Anti-cancer drugs. 28 (6), p. . [Online].